Pharmacogenomics of anticancer drugs: Personalising the choice and dose to manage drug response. (2021)

First Author: Carr DF
Attributed to:  Centre for Drug Safety Science (CDSS) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/bcp.14407

PubMed Identifier: 32501544

Publication URI: http://europepmc.org/abstract/MED/32501544

Type: Journal Article/Review

Volume: 87

Parent Publication: British journal of clinical pharmacology

Issue: 2

ISSN: 0306-5251